Minerva Neurosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Minerva Neurosciences, Inc. (NERV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-05-12
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-03-31 was 0.00 shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-03-31 was 0.00 shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 0.00 shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2017-09-30 was 212.50K shares, a 254.17% increase year-over-year.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 1.88M shares, a 4.61% decline from fiscal 2014.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 1.98M shares, a 205.39% increase from fiscal 2013.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 646.76K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-12 | ||||
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-12 | ||||
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-04 | ||||
| 2017-09-30 | 212.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 290.00K shares derived: sum of 2 quarters · filed 2017-11-06 | 435.00K shares 10-Q · filed 2017-11-06 | ||
| 2017-06-30 | 77.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 222.50K shares 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | 145.00K shares 10-Q · filed 2017-05-04 | ||||
| 2016-09-30 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 182.50K shares derived: sum of 2 quarters · filed 2016-11-03 | 182.50K shares 10-Q · filed 2016-11-03 | 992.83K shares derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | 122.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 122.50K shares 10-Q · filed 2016-08-04 | 932.83K shares derived: sum of 3 quarters · filed 2016-08-04 | 1.16M shares derived: sum of 4 quarters · filed 2016-08-04 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-03 | 810.33K shares derived: sum of 2 quarters · filed 2016-05-03 | 1.04M shares derived: sum of 3 quarters · filed 2016-05-03 | 1.86M shares derived: sum of 4 quarters · filed 2016-05-03 | |
| 2015-12-31 | 810.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 1.04M shares derived: sum of 2 quarters · filed 2016-03-14 | 1.86M shares derived: sum of 3 quarters · filed 2016-03-14 | 1.88M shares 10-K · filed 2016-03-14 | |
| 2015-09-30 | 225.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 1.05M shares derived: sum of 2 quarters · filed 2015-11-05 | 1.07M shares 10-Q · filed 2015-11-05 | 1.07M shares derived: sum of 4 quarters · filed 2015-11-05 | |
| 2015-06-30 | 823.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 848.78K shares 10-Q · filed 2015-08-05 | 848.78K shares derived: sum of 3 quarters · filed 2015-08-05 | ||
| 2015-03-31 | 25.00K shares 10-Q · filed 2015-05-07 | 25.00K shares derived: sum of 2 quarters · filed 2015-05-07 | |||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | 1.98M shares 10-K · filed 2015-03-26 | |||
| 2014-09-30 | 1.98M shares 10-Q · filed 2014-11-06 | ||||
| 2014-07-07 | 480.10K shares 10-K · filed 2015-03-26 | ||||
| 2013-12-31 | 646.76K shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |